The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Closely watched data from Eli Lilly and Viking Therapeutics this month have reignited the discussion around oral weight-loss ...

Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight ...

Dr. Mayo points out that we wake up in the morning after not eating or drinking anything for at least eight hours. That means ...

Subtle symptoms like bowel habit changes and persistent fatigue could be signals of colon cancer. Being alert to these early signs—especially in younger adults—can make all the difference.

Roche's Genentech unit has started work on a $700 million manufacturing facility in North Carolina, part of a promised $50 ...

Exercise is a key component of osteoarthritis management, Garbarino stresses. Joints don’t like to be stiff; try low-impact aerobic exercises like walking, swimming and cycling, which tend to be a ...